Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
41,398,739
-
Share change
-
-171,648
-
Total reported value
-
$5,397,605,243
-
Put/Call ratio
-
76%
-
Price per share
-
$130.30
-
Number of holders
-
880
-
Value change
-
-$45,866,179
-
Number of buys
-
326
-
Number of sells
-
459
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2022
As of 31 Mar 2022 ISHARES TR - ISHARES BIOTECH (IBB) had 880 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 41,398,739 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, CITIGROUP INC, GOLDMAN SACHS GROUP INC, ROYAL BANK OF CANADA, BNP PARIBAS ARBITRAGE, SA, WELLS FARGO & COMPANY/MN, JANE STREET GROUP, LLC, and JPMORGAN CHASE & CO.
This table shows 880 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.